- decreased bone mineral density / IMPC
- decreased circulating calcium level / IMPC
- decreased body length / IMPC
- abnormal retina morphology / IMPC
- abnormal gait / IMPC
- abnormal startle reflex / IMPC
- increased circulating phosphate level / IMPC
- abnormal eye morphology / IMPC
- increased mean corpuscular volume / IMPC
- decreased circulating triglyceride level / IMPC
- short tibia / IMPC
- decreased hemoglobin content / IMPC
- decreased erythrocyte cell number / IMPC
- decreased circulating alkaline phosphatase level / IMPC
- thrombocytopenia / IMPC
- decreased lean body mass / IMPC
- abnormal response to tactile stimuli / IMPC
- increased circulating aspartate transaminase level / IMPC
- decreased circulating serum albumin level / IMPC
- decreased circulating total protein level / IMPC
- decreased circulating sodium level / IMPC
- increased mean corpuscular hemoglobin concentration / IMPC
- decreased circulating amylase level / IMPC
- decreased grip strength / IMPC
- increased bone mineral content / IMPC
B6Dnk;B6N-Slc38a10tm2a(EUCOMM)Wtsi/H
Status | Available to order |
EMMA ID | EM:04231 |
International strain name | B6Dnk;B6N-Slc38a10tm2a(EUCOMM)Wtsi/H |
Alternative name | EPD0023_1_F07 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Slc38a10tm2a(EUCOMM)Wtsi |
Gene/Transgene symbol | Slc38a10 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | MRC, Medical Research Council |
Provider affiliation | Mary Lyon Centre at MRC Harwell |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0023_1_F07. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Animals used for archiving | homozygous C57BL/6Dnk |
Breeding at archiving centre | Chimeras mated to C57BL/6N Tac Den and maintained on this background thereafter. |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- lipid deposition / IMPC
- decreased body length / IMPC
- decreased body weight / IMPC
- abnormal cranium morphology / IMPC
- lipid depletion / IMPC
- increased mean corpuscular volume / IMPC
- short tibia / IMPC
- decreased circulating serum albumin level / IMPC
- increased bone mineral content / IMPC
- abnormal bone structure / IMPC
- abnormal gait / IMPC
- decreased circulating alkaline phosphatase level / IMPC
- thrombocytopenia / IMPC
- decreased circulating triglyceride level / IMPC
- abnormal response to tactile stimuli / IMPC
- decreased total body fat amount / IMPC
- abnormal startle reflex / IMPC
- decreased lean body mass / IMPC
- decreased circulating calcium level / IMPC
- decreased circulating sodium level / IMPC
- decreased hemoglobin content / IMPC
- abnormal eye morphology / IMPC
- decreased circulating amylase level / IMPC
- decreased erythrocyte cell number / IMPC
- decreased bone mineral content / IMPC
- increased circulating aspartate transaminase level / IMPC
- increased circulating phosphate level / IMPC
- abnormal retina morphology / IMPC
- decreased circulating total protein level / IMPC
- decreased grip strength / IMPC
- abnormal maxilla morphology / IMPC
- decreased bone mineral density / IMPC
- increased mean corpuscular hemoglobin concentration / IMPC
- increased circulating iron level / IMPC
MGI phenotypes (gene matching)
- fragile skeleton / MGI
- decreased bone mineral density / MGI
- decreased circulating calcium level / MGI
- abnormal cranium morphology / MGI
- abnormal maxilla morphology / MGI
- abnormal liver physiology / MGI
- decreased body length / MGI
- decreased body weight / MGI
- decreased hemoglobin content / MGI
- decreased erythrocyte cell number / MGI
- decreased circulating alkaline phosphatase level / MGI
- decreased lean body mass / MGI
- decreased length of long bones / MGI
- increased energy expenditure / MGI
- increased oxygen consumption / MGI
- decreased circulating serum albumin level / MGI
- increased circulating creatinine level / MGI
- decreased circulating total protein level / MGI
- decreased circulating amylase level / MGI
- decreased total body fat amount / MGI
- decreased bone mineral content / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).